Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 1, 2005, Pages 118-122

  Ono, Santa Jeremy ^a,c   Abelson, Mark B ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Allergic; conjunctivitis; eye

Indexed keywords

ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

CATARACT; CLINICAL FEATURE; COMPRESSION; CORNEA DISEASE; CRYOTHERAPY; DISEASE CLASSIFICATION; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERENNIAL ALLERGIC CONJUNCTIVITIS; PRIORITY JOURNAL; REVIEW; SEASONAL ALLERGIC CONJUNCTIVITIS; SIDE EFFECT;

EID: 11344288457     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.10.042     Document Type: Article

References (25)

1. M.B. Abelson, and M.R. Allansmith Histamine in the eye A. Silverstein G. O'Connor Immunology and immunopathology of the eye 1979 Masson Publishing New York 362 364
2. K.E. Langley, J.R. Patrinely, R.L. Anderson, and S.M. Thiese Unilateral blepharochalasis Ophthalmic Surg 18 1987 594 598
3. R.M. Lavker, and A.M. Kligman Chronic heliodermatitis: a morphologic evaluation of chronic actinic dermal damage with emphasis on the role of mast cells J Invest Dermatol 90 1988 325 330
4. Berger WE, Lanier BQ, Abelsn MB. Evaluation of the effect of an adjuvant therapy of olopatadine HCl 0.1% ophthalmic solution on quality of life of patients with allergic rhinitis using systemic and/or nasal therapy. Presented at: ACAAI; November 12-17, 2004; Boston, Mass.
5. M.D. Crampton A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model Clin Ther 24 2002 1800 1808
6. M.B. Abelson, and D. Turner A randomized, double blind, parallel group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis Clin Ther 25 2003 931 946
7. D. Welch, G.W. Ousler 3rd, L.A. Nally, M.B. Abelson, and K.A. Wilcox Ocular drying associated with oral antihistamines (loratadine) in the normal population-an evaluation of exaggerated dose effect Adv Exp Med Biol 506 Pt B 2002 1051 1055
8. Gupta G, Ousler GW, Pollard SD, Abelson MB. The comparative ocular drying effects between Claritin and Zyrtec in normal adults. ARVO Abstract no. 70. Available at: www.arvo.org.
9. M.B. Abelson, A.A. Leonardi, L.M. Smith, I.A. Fregona, M.A. George, and A.G. Secchi Histaminase activity in patients with vernal keratoconjunctivitis Ophthalmology 102 1995 1958 1963
10. D. Miyazaki, T. Nakamura, N. Komatsu, N. Nawata, Y. Ikeda, and Y. Inoue Roles of chemokines in ocular allergy and possible therapeutic strategies Cornea 23 suppl 2004 S48 S54
11. S.J. Ono, T. Nakamura, M. Ohbayashi, M. Dawson, Y. Ikeda, and A.K. Nugent Expression profiling: opportunities and pitfalls and impact on the study and management of allergic diseases J Allergy Clin Immunol 112 2003 1050 1056
12. V.G. Bundoc, and A. Keane-Myers Animal models of ocular allergy Curr Opin Allergy Clin Immunol 3 2003 375 379
13. S.J. Ono, T. Nakamura, D. Miyazaki, M. Ohbayashi, M. Dawson, and M. Toda Chemokines: roles in leukocyte development, trafficking, and effector function J Allergy Clin Immunol 111 2003 1185 1199
14. A. Nishimura, R.S. Campbell-Meltzer, K. Chute, J. Orrell, and S.J. Ono Genetics of allergic disease: evidence for organ-specific susceptibility genes Int Arch Allergy Immunol 124 2001 197 200
15. S.J. Ono Vernal keratoconjunctivitis: evidence for immunoglobulin E-dependent and immunoglobulin E-independent eosinophilia Clin Exp Allergy 33 2003 279 281
16. D.P. Metz, M. Hingorani, V.L. Calder, R.J. Buckley, and S.L. Lightman T-cell cytokines in chronic allergic eye disease J Allergy Clin Immunol 100 1997 817 824
17. J.P. Allam, E. Klein, T. Bieber, and N. Novak Transforming growth factor-beta1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1a dendritic cells in vitro J Invest Dermatol 123 2004 676 682
18. D. Miyazaki, G. Liu, L. Clark, and S.J. Ono Prevention of acute allergic conjunctivitis and late-phase inflammation with immunostimulatory DNA sequences Invest Ophthalmol Vis Sci 41 2000 3850 3855
19. A.M. Keane-Myers, D. Miyazaki, G. Liu, I. Dekaris, and S.J. Ono Prevention of allergic eye disease by treatment with IL-1 receptor antagonist Invest Ophthalmol Vis Sci 40 1999 3041 3046
20. E.B. Cook, J.L. Stahl, S.T. Miller, J.E. Gern, K.A. Sukow, and F.M. Graziano Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor-alpha from mast cells affects intercellular adhesion molecule 1 expression on epithelial cells Invest Ophthalmol Vis Sci 39 1998 336 343
21. Miyazaki D, Nakamura T, Toda M, Ohbayashi M, Sherry B, Richardson RM, et al. Requirement of MIP1α as an obligate costimulatory signal for mast cell degranulation in the conjunctiva. J Clin Invest. In press.
22. T. Nakamura, M. Toda, M. Ohbayashi, and S.J. Ono Detailed criteria for the assessment of clinical symptoms in a new murine model of severe allergic conjunctivitis Cornea 22 suppl 7 2003 S13 S18
23. A. Leonardi, P.J. Jose, H. Zhan, and V.L. Calder Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis Ophthalmology 110 2003 487 492
24. Nakamura T, Larkin F, Ikeda Y, Ohbayashi M, Toda M, Wilkins M, et al. CAT-213, a specific monoclonal anti-eotaxin-1 human antibody, inhibits human conjunctival mast cell activation. In: Immunology 2004. Bologna: Medimond International Proceedings; 2004. p. 527-30.
25. Toda, M, Nakamura T, Richardson RM, Ono SJ. Signaling-cross talk between Fc(epsilon)RI and CC chemokine receptor1 in mast cells. Immunology 2004, Medimond International Proceedings; 2004. p. 517-20.